Biotechnology
Today, cancer patients around the world will get more out of life, thanks to a remarkable therapeutic drug used during chemotherapy to stimulate the production of red blood cells and combat the debilitating effects of anemia. And at Marshall, Gerstein & Borun, that makes us feel good, too.
Back in 1983, the startup company that cloned the gene for this medication turned to the Marshall, Gerstein & Borun biotechnology team to help protect its discovery. Twenty years on, the patent applications written by our attorneys have withstood not only the breathtaking changes in the field of biotechnology, but challenges in courts and patent offices throughout the U.S., Europe and the Pacific Rim, as well. The result? Our client enjoys the rewards of its creativity, while millions of individuals experience the benefits of better health.
So if you're looking for a prescription for better business, look to the Marshall, Gerstein & Borun biotechnology team.
